Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

491 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy.
D'Erasmo L, Cefalù AB, Noto D, Giammanco A, Averna M, Pintus P, Medde P, Vigna GB, Sirtori C, Calabresi L, Pavanello C, Bucci M, Sabbà C, Suppressa P, Natale F, Calabrò P, Sampietro T, Bigazzi F, Sbrana F, Bonomo K, Sileo F, Arca M. D'Erasmo L, et al. Among authors: calabro p. Adv Ther. 2017 May;34(5):1200-1210. doi: 10.1007/s12325-017-0531-x. Epub 2017 Apr 21. Adv Ther. 2017. PMID: 28432645
The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy.
Gragnano F, Sperlongano S, Golia E, Natale F, Bianchi R, Crisci M, Fimiani F, Pariggiano I, Diana V, Carbone A, Cesaro A, Concilio C, Limongelli G, Russo M, Calabrò P. Gragnano F, et al. Among authors: calabro p. Mediators Inflamm. 2017;2017:5620314. doi: 10.1155/2017/5620314. Epub 2017 May 28. Mediators Inflamm. 2017. PMID: 28634421 Free PMC article. Review.
Adherence to proprotein convertase subtilisin/kexin 9 inhibitors in high cardiovascular risk patients: an Italian single-center experience.
Gragnano F, Natale F, Concilio C, Fimiani F, Cesaro A, Sperlongano S, Crisci M, Limongelli G, Calabrò R, Russo M, Golia E, Calabrò P. Gragnano F, et al. Among authors: calabro r, calabro p. J Cardiovasc Med (Hagerstown). 2018 Feb;19(2):75-77. doi: 10.2459/JCM.0000000000000611. J Cardiovasc Med (Hagerstown). 2018. PMID: 29251697 No abstract available.
Lomitapide in homozygous familial hypercholesterolemia: cardiology perspective from a single-center experience.
Sperlongano S, Gragnano F, Natale F, D'Erasmo L, Concilio C, Cesaro A, Golia E, Crisci M, Sperlongano R, Fimiani F, Russo M, Arca M, Limongelli G, Calabrò P. Sperlongano S, et al. Among authors: calabro p. J Cardiovasc Med (Hagerstown). 2018 Mar;19(3):83-90. doi: 10.2459/JCM.0000000000000620. J Cardiovasc Med (Hagerstown). 2018. PMID: 29389816
Impact of PCSK9 inhibitors on the quality of life of patients at high cardiovascular risk.
Cesaro A, Gragnano F, Fimiani F, Moscarella E, Diana V, Pariggiano I, Concilio C, Natale F, Limongelli G, Bossone E, Calabrò P. Cesaro A, et al. Among authors: calabro p. Eur J Prev Cardiol. 2020 Mar;27(5):556-558. doi: 10.1177/2047487319839179. Epub 2019 Mar 26. Eur J Prev Cardiol. 2020. PMID: 30913901 No abstract available.
[Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts].
Lettino M, Zambon A, Musumeci G, Arca M, Bilato C, Brunetti ND, Calabrò P, Casu G, Chiarella F, Faggiano P, Ferlini M, Guardigli G, Imbalzano E, Indolfi C, Marcucci R, Menozzi A, Mureddu GF, Filardi PP, Pirro M, Pisciotta L, Scherillo M, Suppressa P, Uguccioni M, Varbella F, Gentile L, Rapezzi C, Averna M. Lettino M, et al. Among authors: calabro p. G Ital Cardiol (Rome). 2020 Apr;21(4 Suppl 1):3S-21S. doi: 10.1714/3331.33006. G Ital Cardiol (Rome). 2020. PMID: 32202541 Italian.
491 results